AnteCancerM

Genetic risk tests for prostate cancer, colorectal cancer and melanoma
Risk assessment of the three cancers with medical recommendations
Recommended for men aged 40-70
Official healthcare service

Important information

E-mail *

Test results are connected to the e-mail you provide.

Post-test consultation

No

Yes (+50.00 €)

Service price:	225.00 €
Additional options total:
Order total:

The test results provide answers to the following questions:

View AntePC sample report

What is my genetic risk level of specific cancers?
At what age should I start cancer screening?
Should I take additional measures to prevent cancer?
What can I do to reduce my risk of cancer?
What changes and symptoms do I need to look out for regarding cancer?

Changing people's lives

Early detection makes a difference

3

Every 3rd man gets cancer during their lifetime.
1

Prostate cancer is the no 1 most common malignancy in men, accounting for 25% of all cancers. But in the early stages of the disease, prostate cancer can be successfully treated.
1

Colorectal cancer is no 1 cause of cancer deaths in people under age 60. But colorectal cancer is avoidable or highly treatable if detected early.

Personalised cancer prevention is an up-to-date solution aimed at minimising the potential impact of three different cancers by tailoring it to your genetic risk level.

Tests take into account your unique characteristics – genetic composition, sex, age and ethnicity – which make your results fully personalised.

Personalised cancer prevention is meant for all men aged 40-70.

Research has shown that the genetic predisposition of many cancers is due to variants in many genes, meaning it is polygenic. Antegenes assesses a person’s risk of developing cancer using polygenic risk score technology, which is developed based on extensive international research. The polygenic risk score (PRS) sums up information over hundreds to thousands of genetic variants in the human genome. By combining the PRS with a person’s background (origin, age and gender), we are able to calculate a person’s risk of developing cancer and provide medical advice on prevention and early detection.

Based on the test results, you will receive personalised preventive recommendations from leading medical experts in the field. This guidance includes when and how to initiate cancer screening and other effective strategies to reduce your risks.

Armed with scientifically backed and well-documented medical advice, you are equipped to take preventive measures within your local healthcare system to proactively protect your health.

Approved by doctors and customers

Over 16 000 tests taken

"As a result of the Antegenes genetic test, I know that my risk of prostate cancer is elevated, and the test report provided solid medical guidance on how to routinely check my health. This knowledge gave me the conviction that I have to check my health earlier and regularly. Before any complaints appear."

Andres, 46
"For me, the greatest value is the information that I need to undergo cancer screening much earlier than the national plan suggests. The body awareness instructions provided by Antegenes are clear and easy to understand, helping me to transform my daily habits. I now also know which signs and changes I need to pay attention to."

Olar, 43
"It's convenient to collect the sample at home at a suitable time. The description of the results is comprehensive, the recommendations are understandable, and they are available for later reference. All in all, the Antegenes genetic risk testing gave me peace of mind."

Alar, 43

We’re here to answer your questions

What does AnteCancerM test include?

Personalised cancer prevention for men is based on the AnteCancerM test, which includes genetic risk testing for prostate cancer, colorectal cancer and skin melanoma.
AnteCancerM Test Limitations
- AnteCancerM test is not used to diagnose prostate, colorectal cancer and melanoma.
- An elevated risk estimated by the AnteCancerM test does not mean that you will develop prostate, colorectal cancer or melanoma during your lifetime. Also, a moderate or lower risk does not mean that the probability of developing the diseases is zero.
- AnteCancerM test does not assess the risk of the your family and relatives, i.e. polygenic risk score-based disease risks may not be transmitted directly from parents to children.
- AnteCancerM does not analyze rare pathogenic mutations in prostate, colorectal and melanoma genes that significantly increase the risk of developing the cancers.
- The AnteCancerM test is based on the most up-to-date scientific data, which may, however, be supplemented and changed in the future as additional information becomes available. The field of genetics is constantly evolving, which may lead to changes in risk assessments over time, as well as changes in test selection recommendations and clinical recommendations based on test results.
- Different polygenic risk scores predicting risks of the same trait may give different estimates of the individual’s risks due to differences in the genetic variants included in the models and their weights.
- The results of this test should be applied in context with other relevant clinical data. In addition to the possible genetic predisposition, other risk factors also influence the risk of prostate, colorectal cancer and melanoma.

How it works?

1 Choose your tests
Select from our range of specialized tests tailored to your health and wellness needs.
2 Prepare for sampling
Receive easy-to-follow instructions for a convenient sample collection process in the comfort of your own home.
3 Provide a sample
Use the provided kit to collect a sample, following guidelines to capture the genetic information needed for testing.
4 Receive your results
Receive results quickly, accompanied by recommendations and guidance for your next steps.